These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 9861225)

  • 1. Enzyme replacement therapy for Gaucher's disease: the early Canadian experience.
    MacKenzie JJ; Amato D; Clarke JT
    CMAJ; 1998 Nov; 159(10):1273-8. PubMed ID: 9861225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The health-related quality of life of adults with Gaucher's disease receiving enzyme replacement therapy: results from a retrospective study.
    Damiano AM; Pastores GM; Ware JE
    Qual Life Res; 1998 Jul; 7(5):373-86. PubMed ID: 9691718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enzyme therapy in children with severe forms of Gaucher's disease].
    Zeman J; Hrebícek M; Vepreková L; Kytnarová J; Houstková H; Malinová V; Hodanová K; Poupĕtová H; Ledvinová J; Hoza J
    Cas Lek Cesk; 1997 Feb; 136(3):95-7. PubMed ID: 9221177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing public payment for high-cost, high-benefit treatment: enzyme replacement therapy for Gaucher's disease in Ontario.
    Clarke JT; Amato D; Deber RB
    CMAJ; 2001 Sep; 165(5):595-6. PubMed ID: 11563212
    [No Abstract]   [Full Text] [Related]  

  • 5. Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gaucher's disease using the bone marrow burden score.
    Robertson PL; Maas M; Goldblatt J
    AJR Am J Roentgenol; 2007 Jun; 188(6):1521-8. PubMed ID: 17515371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A less costly regimen of alglucerase to treat Gaucher's disease.
    Figueroa ML; Rosenbloom BE; Kay AC; Garver P; Thurston DW; Koziol JA; Gelbart T; Beutler E
    N Engl J Med; 1992 Dec; 327(23):1632-6. PubMed ID: 1435900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alglucerase. A review of its therapeutic use in Gaucher's disease.
    Whittington R; Goa KL
    Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme replacement therapy decreases hypergammaglobulinemia in Gaucher's disease.
    Deibener J; Kaminsky P; Jacob C; Dousset B; Klein M; Duc M
    Haematologica; 1998 May; 83(5):479-80. PubMed ID: 9658738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological features in Gaucher's disease during enzyme replacement therapy.
    Ono H; Fujiwara M; Ito K; Ueda H; Mizoguchi N; Sakura N
    Acta Paediatr; 2001 Feb; 90(2):229-31. PubMed ID: 11236058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaucher's disease in Lithuania: its diagnosis and treatment.
    Kleinotienė G; Tylki-Szymanska A; Czartoryska B
    Medicina (Kaunas); 2011; 47(7):405-11. PubMed ID: 22112991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaucher's disease: a review.
    Morales LE
    Ann Pharmacother; 1996 Apr; 30(4):381-8. PubMed ID: 8729893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uveitis in Gaucher disease.
    Dweck A; Rozenman J; Ronen S; Zimran A; Elstein D
    Am J Ophthalmol; 2005 Jul; 140(1):146-7. PubMed ID: 16038664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
    Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE
    N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gaucher's disease--ocular manifestation and treatment].
    Filipek E; Koraszewska-Matuszewska B
    Klin Oczna; 2006; 108(7-9):357-60. PubMed ID: 17290842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic assessment of pulmonary hypertension in Gaucher's disease.
    Elstein D; Klutstein MW; Lahad A; Abrahamov A; Hadas-Halpern I; Zimran A
    Lancet; 1998 May; 351(9115):1544-6. PubMed ID: 10326537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gaucher's disease and fatal hepatic fibrosis despite prolonged enzyme replacement therapy.
    Perel Y; Bioulac-Sage P; Chateil JF; Trillaud H; Carles J; Lamireau T; Guillard JM
    Pediatrics; 2002 Jun; 109(6):1170-3. PubMed ID: 12042560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy.
    Burrow TA; Cohen MB; Bokulic R; Deutsch G; Choudhary A; Falcone RA; Grabowski GA
    J Pediatr; 2007 Feb; 150(2):202-6. PubMed ID: 17236903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taliglucerase alfa for the treatment of Gaucher's disease.
    Haddley K
    Drugs Today (Barc); 2012 Aug; 48(8):525-32. PubMed ID: 22916340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical outcomes of 2 pediatric patients with Gaucher's disease in enzyme replacement therapy for 9 years].
    Quijada Fraile P; Martín Hernández E; Teresa García-Silva M
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():43-5. PubMed ID: 22230125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [French results of enzyme replacement therapy in Gaucher's disease].
    Schaison G; Caubel I; Belmatoug N; Billette de Villemeur T; Saudubray JM
    Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.